GET THE APP

Journal of Antivirals & Antiretrovirals

Journal of Antivirals & Antiretrovirals
Open Access

ISSN: 1948-5964

+44 1300 500008

Journal of Antivirals & Antiretrovirals : Citations & Metrics Report

Articles published in Journal of Antivirals & Antiretrovirals have been cited by esteemed scholars and scientists all around the world. Journal of Antivirals & Antiretrovirals has got h-index 22, which means every article in Journal of Antivirals & Antiretrovirals has got 22 average citations.

Following are the list of articles that have cited the articles published in Journal of Antivirals & Antiretrovirals.

  2022 2021 2020 2019 2018

Year wise published articles

32 59 77 13 11

Year wise citations received

172 256 226 169 197
Journal total citations count 1776
Journal impact factor 5.32
Journal 5 years impact factor 5.62
Journal cite score 5.3
Journal h-index 22
Journal h-index since 2018 17
Important citations (1101)

bokhari na, siddiqui i, perveen k, siddique i, alwahibi ms, et al. (2014) potential of different parts of neem (azadirachta indica) extracts in controlling rhizoctonia solani infestation. international journal of agriculture & biology 1: 16.

behbahani m, sayedipour s, pourazar a, shanehsazzadeh m (2014) in vitro anti-hiv-1 activities of kaempferol and kaempferol-7-o-glucoside isolated from securigera securidaca. research in pharmaceutical sciences 9: 463.

moradi mt, rafieian-kopaei m, karimi a (2016) a review study on the effect of iranian herbal medicines against in vitro replication of herpes simplex virus. avicenna journal of phytomedicine 6: 506.

tofighi z, molazem m, doostdar b, taban p, shahverdi ar, et al. (2015) antimicrobial activities of three medicinal plants and investigation of flavonoids of tripleurospermum disciforme. iranian journal of pharmaceutical research: ijpr 14: 225.

ghannadi a, fattahian k, shokoohinia y, behbahani m, shahnoush a (2014) anti-viral evaluation of sesquiterpene coumarins from ferula assa-foetida against hsv-1. iranian journal of pharmaceutical research: ijpr 13: 523.

dilintas a (2011) the emerging threat of coronavirus respiratory syndrome middle east (mers-cov).

a health, welfare tn, educational at (2011) o coronavirus middle east respiratory syndrome (mers-cov).

lim sun hee (2015) linical review on the use of ribavirin and interferon in muss infection. journal of pharmacology 59: 245-250.

guery b, grandbastien b, galpérine t, faure k (2015) ebola et autres, ces virus venus d’ailleurs. réanimation 24: s379-s385.

stafylidis s, kafkia t, xatzigeorgiadou m (2014) middle east respiratory syndrome-coronavirus (mers-cov): a new threat? archives of hellenic medicine/arheia ellenikes iatrikes 31: 4.

memish za, al-tawfiq j, drosten c, assiri a, alhakeem r, et al. (2014) log in with. science 10: 2-12.

al-tawfiq ja, memish za (2017) update on therapeutic options for middle east respiratory syndrome coronavirus (mers-cov). expert review of anti-infective therapy.

jadav ss, ganta nm, kumar a, dan n, mohanty np (2016) the updates on middle east respiratory syndrome coronavirus (mers-cov) epidemiology, pathogenesis, viral genome and currently available drugs. journal of pharmaceutical chemistry 3: 10-18.

moniri a, marjani m, tabarsi p, yadegarynia d, nadji sa (2015) health care associated middle east respiratory syndrome (mers): a case from iran. tanaffos 14: 262.

modjarrad k (2010) research and development activities for middle east respiratory syndrome: the current landscape.

malik m, elkholy aa, khan w, hassounah s, abubakar a, et al. (2010) qrsla Ø©ysfntla Ø©mzaltmla Ø©ylbqtsmla tarabtaalau.

malik m, elkholy aa, khan w, hassounah s, abubakar a, et al. (2010) qrsla Ø©ysfntla Ø©mzaltmla Ø©ylbqtsmla tarabtaalau.

abofaye ma (2011) outbreak severity index: the international response to the global outbreaks.

al-ahmari a (2015) is secondary hemophagocytic lymphohistiocytosis behind the high fatality rate in middle east respiratory syndrome corona virus? journal of applied hematology 6: 1.

malik m, mahjour j, opoka m, mafi ar (1995) section menu. information for authors 1.

Top